en.Wedoany.com Reported - At the Veeva R&D and Quality Summit Europe in Copenhagen, Denmark, Veeva Systems showcased its future agentic work platform, Veeva Falcon, and the latest innovations in Vault AI. Industry leaders from AOP Health, Boehringer Ingelheim, GSK, MSD, Novo Nordisk, Roche, and Sanofi shared success stories on simplifying and standardizing operations while building a scalable foundation for AI.
Veeva demonstrated the now-available Vault AI agents and announced plans to launch Vault AI across all Vault applications by August 2026. The company also previewed the Veeva Falcon platform, designed to reduce costs, increase speed, and maintain compliance in drug development. Falcon agentic work is expected to be available to early users by the end of 2026, initially focusing on receiving and quality-checking trial master file documents, regulatory communications with health authorities, and safety case triage and intake.
The event brought together over 2,000 leaders from clinical, regulatory, safety, and quality fields, featuring more than 100 sessions. Attendees shared experiences on accelerating development and manufacturing through connected clinical, regulatory, and quality tools. For example, AOP Health accelerated its journey from development to delivery by connecting R&D, quality, commercial, and data on the Veeva Industry Cloud. Merck KGaA, Darmstadt, Germany, optimized data to lay the foundation for AI and automation in regulatory affairs.
In improving collaboration with clinical sites and research centers, Boehringer Ingelheim showcased end-to-end clinical operations to connect with sites and patients. GSK standardized site engagement to accelerate startup and improve performance. Boehringer Ingelheim and Roche streamlined site payments to enhance collaboration. Novo Nordisk, Sobi, and Syneos Health Consulting gained full data ownership and improved clinical efficiency by connecting electronic data capture with clinical databases.
In modernizing quality, safety, and compliance, Haleon and Sanofi prepared for agentic AI in quality, prioritizing efficiency gains. Novo Nordisk streamlined pharmacovigilance to improve efficiency and overall data management. UCB modernized system validation to support good practice implementation and ongoing compliance.
Rik van Mol, Senior Vice President of Veeva Development Cloud, stated that the ideas shared and connections made at the summit will extend beyond the event, driving the industry toward an agentic work future. Vault AI and Veeva Falcon represent a significant step in the application of AI in life sciences, promising greater speed and efficiency.
This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com
